Business · 05/03/2003
FDA Reopens Comment Period for Dietary Supplements Containing Ephedrine Alkaloids
The Food and Drug Administration (FDA) is reopening the comment period for 30 days to receive feedback on new scientific evidence highlighting health risks associated with dietary supplements containing ephedrine alkaloids, as well as a proposed warning statement on product labels.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →